WCN26-3605 NOVEL INSIGHTS INTO PHARMACOKINETICS OF INTRAPERITONEAL CEFEPIME DURING AUTOMATED PERITONEAL DIALYSIS USING MONTE CARLO SIMULATIONS

Read full text Summarise with VIRAT
Authors: Dominik Tüchler, Huiping Huang, Birgit Pfaller, Maximilian Lanzerits, Sarah Halmer, Christian Baumgartner, Klaudia Riml-Pany, Michaela Mittelstrasser, Camille Fournier, Manuel Kussmann, Martin Wiesholzer, Uwe Fuhr
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The International Society for Peritoneal Dialysis (ISPD) guidelines currently recommend intraperitoneal (IP) administration of cefepime, a fourth-generation cephalosporin, as a first-line monotherapy for infectious peritoneal dialysis-associated peritonitis (PDAP). Despite this, data on the pharmacokinetics (PK) of cefepime and its optimal dosing in automated peritoneal dialysis (APD) remain limited. This study aimed to characterize the PK of cefepime in APD patients and to predict the probability of achieving pharmacokinetic/pharmacodynamic (PK/PD) targets during short versus long-dwell periods using Monte Carlo simulations.

Fields of Study & Subjects

Antibiotics Pharmacokinetics and Efficacy Dialysis and Renal Disease Management Neutropenia and Cancer Infections

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105869–105869
Publication date
25 March 2026
Language
EN